ReShape Lifesciences Inc (RSLS) — Cash Flow Quality Index

Latest as of March 2025: -1.44x

ReShape Lifesciences Inc (RSLS) has a Cash Flow Quality Index of -1.44x as of March 2025. Operating cash flow of $-2.12 Million is below net income of $1.47 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore ReShape Lifesciences Inc total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-1.44x

Operating CF / Net Income

Operating Cash Flow

$-2.12 Million

USD

Net Income

$1.47 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for ReShape Lifesciences Inc (None–None)

Year-by-year earnings quality comparison for ReShape Lifesciences Inc. For live market cap and the full company financial profile, see RSLS market cap.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.